Compare AbCellera Biologics Inc (ABCL) vs Medtronic PLC (MDT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AbCellera Biologics Inc vs Medtronic PLC — how do they compare? AbCellera Biologics Inc trades at $8.99 (market cap $2.99B), while Medtronic PLC trades at $90.5 (market cap $116.07B). The key difference: Medtronic PLC is far larger — about 38.8× AbCellera Biologics Inc's market cap, and Medtronic PLC pays a 3.18% dividend while AbCellera Biologics Inc pays none. Which is the better fit depends on your goals.
| ABCL | MDT | |
|---|---|---|
Market Cap | $2.99B | $116.07B |
Sector | Health | Health |
52-Week High | $9.76 | $105.35 |
52-Week Low | $2.78 | $73.75 |
Enterprise Value | $2.58B | $134.82B |
Dividend Yield | — | 3.18% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AbCellera Biologics Inc
AbCellera Biologics Inc is a biotechnology company. It develops antibodies to treat infectious diseases and various other types of diseases. The company's AI-powered technology sources, searches, decodes and analyzes antibody responses to engineer new antibody drug candidates for its partners.
Read more on ABCL →About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →
